baber/WOPTO huggingface dataset:
Patent EP-0731125-A1 (EP)
Inventor: TONELLI CLAUDIO
IPC: C08G65/00
Filed: 1996-02-27
Abstract: Use of fluorinated polymers based on fluoropolyethers for the preparation of crosslinkable high dry formulations comprising a fluorinated part R F  and optionally an hydrogenated part R H , not containing groups capable of linking by means of hydrogen bonds to basic acceptors, an hydrogenated part Rh 1  and Rh 2 , wherein Rh 1  is equal to or different from Rh 2 , and Rh 1  and/or Rh 2  being linking bonds containing at least a functional group capable of linking by means of hydrogen bonds with basic acceptors, the bonds joining the fluorinated part to the hydrogenated part being of ether C-O simple type, the terminals T' a  and T'' being such as to render the structure mono-, bi- or polyfunctional, and subsequent crosslinking of the fluorinated polymer, the monofunctional products being always in admixture with a resin having even a higher functionality than the described type; the preferred fluorinated products have the formula:  
 
        T''-(Rh 2 ) y (R H ) x -R F -(R H ) x -(Rh 1 ) y' T' a
Patent EP-0734976-A1 (EP)
Inventor: HAFNER JOSEF DR ING
IPC: B65G19/02
Filed: 1996-03-29
Abstract: The equipment has carriers for light materials, which can be moved along a rail (2) by a continuously driven pulling guide. The carriers have equipment to make a frictional coupling with the guide, and have control equipment to release the coupling if the carrier encounters an obstacle. The coupling equipment has at least one driving roller (15) which is in contact with the guide, and the control equipment locks the roller positively with respect to the carrier when the obstacle is removed. The control equipment may also have a pivoting lever (39) with a stem (54) which projects at the front of the carrier, and which may release the roller if the stem impacts against an obstacle or a coupling ramp (58).
Patent EP-0738713-A1 (EP)
Inventor: HUANG JAMIN
IPC: A01N43/36
Filed: 1996-04-11
Abstract: Process for preparing complex pesticidal 1-(haloaryl)heterocyclic compounds by reacting 1-(nitroaryl)heterocycles with metallic halide salts.
Patent EP-0757983-A1 (EP)
Inventor: BAEDER GEORG DR
IPC: C07C291/04
Filed: 1996-07-25
Abstract: The prodn. of tert. amine oxides of formula N(R1)(R2)(R3)O (I) comprises reacting a tert. amine of formula NR1R2R3N (II) with an oxygen-releasing cpd. (III) in presence of 1-15 wt% of an amine oxide (based on the reaction mixt.). R1 = 1-3C alkyl; R2 = 1-20C alkyl; and R3 = 6-22C alkyl.
Patent EP-0761690-A1 (EP)
Inventor: KALBE JOCHEN DR
IPC: C08J5/00
Filed: 1996-07-29
Abstract: Novel thermoplastic, biodegradable polysaccharide-esters(or etheresters) are of formula (I): A = linear polyether chain of formula (E-O)n; E = linear aliphatic or aromatic opt. branched 2-11C chain; n = O or an integer; B=D = maleic acid addn. prod. of formula (II); F = aliphatic, satd. or mono- or poly-unsatd. C framework which opt. has further substits.; and C = H, hydroxy-ethyl, -propyl or butyl, Me, Et, benzyl, dihydroxypropyl, carboxyalkyl, sulphoalkyl or cyanoethyl. Pref. (I) contain 0-6.5 mols. alkyl ether and 0.1-3 mols. maleic acid addn. prod., each per mol. polysaccharide units. Alternatively, per mol. of polysaccharide units, (I) contains 0-6.5 mols. alkyl ether, X mols. maleic acid addn. prod. and Y mols. mono- or di-carboxylic acid, with X and Y = 0.1-2.9 and X+Y =3. The maleic acid addn. prod. gps. B and D are of alkane- or alkenyl-succinic acid gps. with 8-18C aliphatic side chains and opt. further substits. and the opt. other acid gps. present are an acetate or a phthalate.
Patent EP-0760390-A1 (EP)
Inventor: NAUWELAERTS FRANS
IPC: C09J7/10
Filed: 1996-08-01
Abstract: The backing strip (2) is provided with additional means of adherence (3-6-7) in order to increase the adhesive force between the backing strip (2) and the adhesion strip (1) and to avoid the curling of the latter when it is applied.
Patent EP-0767476-A1 (EP)
Inventor: GUILLEMINOT PIERRE
IPC: H01H13/14
Filed: 1996-09-24
Abstract: The removable panel (1) includes the pushbutton (2) that forms part of the removable front panel (1) of the car radio. When the panel (1) is in place on the radio, it contacts a protruding actuating rod (3), to operate a cassette player. The pushbutton has a hollow inner section through which a spring mechanism arm (6) is inserted. When the panel is removed from the car radio the spring pushes the pushbutton into the removed front panel.
Patent EP-0827792-A1 (EP)
Inventor: MIDDELDORF HELGE DIPL-ING
IPC: B22D11/053
Filed: 1996-09-09
Abstract: Continuous casting die, especially for steel slab, has copper plates for the wide sides of the die supported by cooled back-up plates, narrow sides clamped between the wide sides, and a vibratory mechanism connected to the back-up plates. The wide side back-up plates (21) are of channel section and have coolant passages (52) formed in the walls, with electromagnetic components (61,62) on support frames (31) positioned within the free space (23) of the channel section.
Patent EP-0770664-A1 (EP)
Inventor: MATSUBARA WATARU
IPC: C08L27/06
Filed: 1996-10-16
Abstract: To present an oil-forming method of chlorine-containing plastic refuse capable of obtaining oily product free from chlorine content, while suppressing apparatus corrosion by efficiently capturing hydrogen chloride generated by decomposition of chlorine-containing plastics, the oil-forming method of chlorine-containing plastic refuse is characterized by decomposing chlorine-containing plastic refuse using water in supercritical region as reaction medium and forming into oil, wherein silver nitrate of 0.8 to 2.0 times the reaction equivalent amount of hydrogen chloride generated by decomposition of chlorine-containing plastic refuse is added in the water as reaction medium to decompose and form into oil, and generated hydrogen chloride is removed in a form of silver chloride.
Patent EP-0726206-A1 (EP)
Inventor: BOUHANNA CLAUDE
IPC: B65D21/06
Filed: 1996-01-31
Abstract: The container (1) has a base (4) and at least three pillars (6a, 6b, 6c) which rise more or less perpendicularly from the base and are located round its edge. The pillars are hollow, open at one end and diverging towards the point where they join the base, allowing them to fit one inside the other. At the lower end of each pillar there is a hinged flap (38) which covers the lower end of the pillar for stacking the containers one on top of another, and exposes the open end of the pillar when the containers are stacked one inside the other.
Patent EP-0732301-A1 (EP)
Inventor: ORGEOLET ALAIN
IPC: F16K15/14
Filed: 1996-03-01
Abstract: The valve for a liquid under pressure consists of a main tube (3) attached by its edge to the free end of the liquid dispenser (2), which has an internal tube (7) of smaller diameter. The two tubes are fixed rigidly together, and the internal one receives a plug (9) with a projecting rim (10) round its head to retain a conical membrane (5) fitted between the two tubes and closing the annular gap between them. When the liquid is flowing through the dispenser the outer edge of the membrane is opened by the pressure of the flow, allowing the liquid to pass. As soon as the flow ceases, the membrane returns to its position against the outer tube's thrust surface, preventing any drips.
Patent EP-0732156-A1 (EP)
Inventor: CHOW SUEZONE
IPC: B09B3/00
Filed: 1996-03-15
Abstract: A process to decontaminate soil containing a chlorinated organic compound. Water is added to the soil to produce a solution of the chlorinated organic compound containing at most about 2% by weight of the compound. Ozone is then passed through the solution to decompose the chlorinated organic compound. The invention is a particular application in decontaminating soil containing chlorophenols, dibenzo-p-dioxins and chlorinated dibenzofurans.
Patent EP-0735801-A1 (EP)
Inventor: CASSESE BRUNO
IPC: H05B41/282
Filed: 1996-03-27
Abstract: The lamp (1) is supplied from the vehicle battery (B) via DC/DC (4) and DC/AC (3) converters. The former, of mono-flyback type, uses an MOS transistor (Q1), switched by an electronic controller (7), to maintain lap power at 35w. The controller also switches the four bridge-connected MOSTs (6) of the DC/AC converter. The square-wave 0.2-1.OkHz lamp voltage normally runs at 65-125v, -negative to frame to maintain envelope transparency and extend lamp life. A high-voltage circuit (2) produces the pulse required to start the lamp. Lamp voltage and current are measured (9) and digitised to form the controller input data. Voltage is measured by a resistance divider an current is repetitively sampled using a resistive shunt, short-circuited between samplings to reduce losses.
Patent EP-0749952-A1 (EP)
Inventor: ALAS MICHEL
IPC: C07C51/56
Filed: 1996-06-19
Abstract: Continuous prepn. of citraconic anhydride comprises introducing itaconic acid (or a starting material contg. it) continuously, with a catalyst, into the reaction mixt. at a temp. such that the itaconic acid is liq. in the reaction conditions.
Patent EP-0750816-A1 (EP)
Inventor: HURD JIM
IPC: H04L29/06
Filed: 1996-01-17
Abstract: Dans un procédé permettant la communication de données entre des stations terminales reliées à des réseaux respectifs basés sur des paquets opérant avec différents protocoles, les paquets d'un premier protocole sont configurés en paquets d'un second protocole dans une unité d'interfonctionnement entre les réseaux. L'unité d'interfonctionnement permet également l'interfonctionnement d'établissements d'appels.
Patent EP-0810287-A1 (EP)
Inventor: ASHIKARI TOSHIHIKO
IPC: C12N15/54
Filed: 1996-02-16
Abstract: Proteins having an aromatic-acyltransferase activity; a gene system coding for the same; a process for producing the proteins using the gene system; and uses of the genes and the proteins. The genes and the proteins acylate plant pigments such as anthocyanin to thereby cause color tone changes, thus providing plants, particularly flowers, having colors that have not been inherent therein.
Patent EP-0812147-A1 (EP)
Inventor: KNOLL MEINARD
IPC: A61B5/1473
Filed: 1996-02-27
Abstract: Implantierbares Sensorsystem zur Bestimmung von Stoffkonzentrationen in lebenden Organismen sowie Verfahren zu seiner Herstellung. Die Erfindung betrifft ein implantierbares Sensorsystem zur Bestimmung von Stoffkonzentrationen in lebenden Organismen, dadurch gekennzeichnet, daß die stofferkennende Oberfläche (1, 1') mindestens eines Sensors (2, 2') mit mindestens einer mikroschlauchartigen permeablen und flexiblen Kapillarmembran (3, 3') verbunden ist, die nach der Implantation einen guten Kontakt mit dem lebenden Organismus eingeht, daß ferner die Kapillarmembran mit einem Stoff (4) gefüllt ist, der den Transport des von außen in das Innere der Kapillarmembran (3, 3') getretenen Analyten zur stofferkennenden Sensoroberfläche (1, 1') erlaubt, daß ferner die Kapillarmembran mit Hilfe eines Kanals (11, 11') in einer Halterung (5, 5') so mit mindestens einem Septum (6, 6') verbunden ist, daß mit Hilfe einer Injektionsnadel Stoffe durch das Septum hindurch dem Inneren der Kapillarmembran hinzugefügt und entnommen werden können. Solche Sensoren lassen sich zur kontinuierlichen Konzentrationsmessung von Glucose, Laktat und anderen Analyten im Gewebe oder Blutgefäßen von Menschen, Tieren und anderen Organismen einsetzen.
Patent EP-0882382-A1 (EP)
Inventor: STEVENSON WILLIAM CHARLES
IPC: H05B33/28
Filed: 1996-02-22
Abstract: Ce procédé sert à fabriquer des lampes électroluminescentes (EL) à faible coût, selon plusieurs étapes. Dans la première étape, on procède à un découpage à l'emporte-pièce, à un emboutissage ou à une attaque chimique d'une feuille de métal, afin de former une ou plusieurs électrodes capacitives postérieures. Dans la deuxième étape, ces électrodes capacitives sont collées à une pièce brute de papier servant de noyau, qui est couplée à un système d'indexage positionné avec précision. Dans la troisième étape, une couche d'encre de phosphore EL est appliquée sur les électrodes capacitives pour former avec précision les zones d'éclairage. Dans la quatrième étape, une couche d'encre ITO conductrice est appliquée de façon è recouvrir la couche d'encre de phosphore EL. Ensuite, dans la cinquième étape, un film de polyester transparent ou un revêtement diélectrique activé par ultraviolets est appliqué sur toute la surface de la lampe. Enfin, dans la sixième étape, des terminaisons électriques sont formées au niveau de l'électrode capacitive postérieure et de la couche d'encre ITO conductrice._____
Patent EP-0823129-A1 (EP)
Title: Chip-abdeckung
Inventor: HOUDEAU DETLEF
IPC: G06K19/077
Filed: 1996-04-09
Abstract: Es wird eine Chip-Abdeckung (5, 6, 11) zur vollständigen oder teilweisen Abdeckung von elektrischen, elektronischen, optoelektronischen und/oder elektromechanischen Komponenten eines Chips (1, 8) beschrieben. Die Chip-Abdeckung (5, 6, 11) zeichnet sich dadurch aus, dass ein Aktivator (12) vorgesehen ist, der im aktivierten Zustand in der Lage ist, die elektrischen, elektronischen, optoelektronischen und/oder elektromechanischen Komponenten des Chips (1, 8) ganz oder teilweise zu zerstören, und der durch den Versuch, die Chip-Abdeckung (5, 6, 11) vom Chip (1, 8) zu entfernen, aktivierbar ist. Auf diese Weise ist es möglich, Fremdanalysen und/oder Manipulationen des Chips (1,8) zuverlässig zu verhindern.
Patent EP-0813538-A1 (EP)
Title: Compositions and methods for the treatment and diagnosis of immune disorders
Inventor: LEVINSON DOUGLAS A
IPC: C12Q1/68
Filed: 1996-03-01
Abstract: The present invention relates to methods and compositions for the treatment of immune disorders, especially T helper (TH) cell and TH cell-like related disorders. First, genes are identified and described which are differentially expressed within and among TH cells and TH cell subpopulations. Second, genes are identified and described which are differentially expressed within TH cell subpopulations in TH cell subpopulation-related disorders. The modulation of the expression of the identified genes and/or activity of the identified gene products can be utilized therapeutically to ameliorate immune disorder symptoms and to modulate TH cell responsiveness, for example, responsiveness to antigen. Further, the identified genes and/or gene products can be used to diagnose individuals exhibiting or predisposed to such immune disorders. Still further, the identified genes and/or gene products can be used to detect TH cell responsiveness, for example, responsivenem to antigen.
Patent EP-0969950-A1 (EP)
Title: Robot industriel
Inventor: FORSLUND KARL-ERIK
IPC: B25J19/00
Filed: 1996-03-28
Abstract: Un robot industriel comporte une base (2) montée sur un pied (1), rotative sur un premier axe vertical (A) et supportant un premier bras de robot (8) rotatif par rapport à celle-ci, sur un second axe horizontal (B). La base comporte un soubassement (4) doté de deux parties saillantes (3a, 3b) qui supportent une pièce intermédiaire (5) qui est rotative par rapport à la base. Ladite pièce intermédiaire comprend deux éléments de support parallèles (6a, 6b) aux extrémités supérieures desquels le premier bras de robot est tourillonné. Les extrémités inférieures des éléments de support sont fixées rotatives au soubassement. Le robot peut ainsi être basculé vers l'avant ou l'arrière et être immobilisé dans ces positions pendant son intervention, ce qui permet d'obtenir différents types de domaines d'action.
Patent EP-0870142-A1 (EP)
Title: Lift valve with pressure balanced pilot operated valve member
Inventor: HAJJAR ELIAS
IPC: F16K31/383
Filed: 1996-05-03
Abstract: A flow control element adapted to be provided within a substantially longitudinal fluid passageway (105) of a valve device, said flow control element comprising: 
a substantially longitudinal element (104) having a cross-sectional area smaller than the cross-sectional area of said passageway (105); 
retaining means to retain said element within said passageway (105) whilst permitting automatic movement of said element relative to said passageway (105); and, 
a biasing means, such as a spring (120), which permits said element (104) to alter its position within said passageway (105); 
such that, said flow control element enables a consistent low flow-rate of fluid through said passageway (105) whilst said automatic movement of said element (104) relative to said passageway (105) cleans and/or clears said passageway (105) from particulate matter such as dirt and/or deposit whilst preventing the ingress of particles which might otherwise clog said passageway (105) and/or flow paths downstream thereof.
Patent EP-0820463-A1 (EP)
Inventor: BRIERLEY RUSSELL A
IPC: C07K1/20
Filed: 1996-04-12
Abstract: Disclosed is an improved process for obtaining purified, monomeric, intact, correctly-folded insulin-like growth factor-I (also known as somatomedin-C). The improvements, consisting primarily of the addition of an IGF-I unfolding/refolding step and the substitution of a reverse phase chromatography step for a gel filtration chromatography step result in a three-fold increase in final yield. The process includes the following steps, in order: first cation exchange, unfolding/refolding, hydrophobic interaction chromatography, second cation exchange, and reverse phase chromatography.
Patent EP-0833829-A1 (EP)
Inventor: GANDOLFI ROBERTO
IPC: C07F7/08
Filed: 1996-06-06
Abstract: The present invention relates to a novel process for the preparation of 1-(3-trialkylsilylphenyl)-2,2,2-trifluoromethyl ethanones from 1-halo-3-trialkylsilanyl-benzenes. 1-(3-trialkylsilylphenyl)-2,2,2-trifluoromethyl ethanones are useful for the treatment of Alzheimer's disease and senile dementia. In addition, the present invention relates to a novel process for purifying 1-(3-trialkylsilylphenyl)-2,2,2-trifluoromethyl ethanones utilizing a novel extraction method.
Patent EP-0835105-A1 (EP)
Inventor: GAUTIER JEAN-CLAUDE
IPC: A61K47/44
Filed: 1996-06-28
Abstract: PCT No. PCT/FR96/01010 Sec. 371 Date Mar. 13, 1998 Sec. 102(e) Date Mar. 13, 1998 PCT Filed Jun. 28, 1996 PCT Pub. No. WO97/02031 PCT Pub. Date Jan. 23, 1997The invention relates to a pharmaceutical composition for parenteral administration, characterized in that it comprises: from 1.5 to 8% by weight of an active principle consisting of amiodarone or one of the pharmaceutically acceptable salts thereof a physiologically acceptable buffer solution capable of solubilizing the active principle and of maintaining the pH of the composition between 2.4 and 3.8 a nonionic hydrophilic surfactant.
Patent EP-0912926-A1 (EP)
Inventor: RAMAGOPAL H S
IPC: G06F5/06
Filed: 1996-07-16
Abstract: L'invention concerne une mémoire tampon de chargement/stockage dans laquelle il est possible de stocker aussi bien des opérations de mémoire de chargement que des opérations de mémoire de stockage. Etant donné que chaque emplacement de stockage peut contenir soit une opération de mémoire de chargement, soit une opération de mémoire de stockage, le nombre d'emplacements de stockage disponibles pour les opérations de mémoire de chargement ne peut pas dépasser le nombre d'emplacements de stockage contenus dans toute la mémoire tampon. De façon similaire, le nombre d'emplacements de stockage disponibles pour des opérations de mémoire de stockage ne peut pas dépasser le nombre d'emplacements de stockage contenus dans toute la mémoire tampon. Cette invention améliore l'utilisation d'une zone de silicium pour des mémoires tampon de chargement et de stockage en offrant, sur une surface plus petite, une mémoire tampon, dont les performances sont équivalentes, pouvant remplacer les mémoires tampon de chargement et de stockage séparées, utilisées jusqu'à maintenant dans des microprocesseurs superscalaires.
Patent EP-0842469-A1 (EP)
Inventor: LANEY CLIFTON W
IPC: G06F11/14
Filed: 1996-07-23
Abstract: Procédé permettant de maintenir l'état courant du système d'exploitation d'un ordinateur (20) sur tout un cycle de mise hors tension/sous tension. Ce procédé consiste à détecter si l'ordinateur (20) doit être mis hors tension (51). Si tel est le cas, l'état de l'ordinateur (20) est maintenu par la mémorisation de données représentant cet état dans une zone indiquée d'une mémoire rémanente (23, 54). Un code d'initialisation système du système d'exploitation est ensuite remplacé par un nouveau code d'initialisation système qui renvoie à un code de redémarrage accédant à la zone indiquée de la mémoire rémanente (23, 55), de sorte que, lorsque l'ordinateur (20) est à nouveau mis sous tension, le code de redémarrage accède à la zone indiquée de la mémoire rémanente (23) afin que les données puissent remettre l'ordinateur (20) à l'état où il était avant d'être mis hors tension.
Patent EP-0837812-A1 (EP)
Inventor: SAVARD FRANCK
IPC: F16H59/00
Filed: 1996-08-01
Abstract: L'objet de l'invention est un dispositif de compensation d'effort pour une commande à câble d'au moins un dérailleur (22) de chaîne notamment fixé sur le cadre (10) d'un vélo à plusieurs plateaux (16, 18, 20), ledit câble (32) coulissant dans une gaine (34) venant en appui sur une butée (32), ledit dérailleur étant équipé d'un ressort de rappel (28) à l'état comprimé lorsque la chaîne est sur le plus grand plateau ou pignon, caractérisé en ce qu'il comprend au moins un élément élastique de rappel (46) à effet antagoniste, disposé entre une butée fixe solidaire du vélo et une butée fixe solidaire du câble, ledit élément élastique de rappel étant à l'état détendu lorsque le ressort de rappel du dérailleur est à l'état comprimé et ledit élément de rappel étant à l'état comprimé lorsque le ressort de rappel du dérailleur est à l'état détendu.
Patent EP-0845036-A1 (EP)
Inventor: CUTTITTA FRANK
IPC: A61P37/08
Filed: 1996-08-16
Abstract: The methods of the present invention demonstrate that adrenomedullin (AM) is expressed in human cancer cell lines of diverse origin and functions as a universal autocrine growth factor driving neoplastic proliferation. The present invention provides for AM peptides and AM antibodies useful in therapeutic, pharmacologic and physiologic compositions. The present invention additionally provides for methods of diagnosis, treatment and prevention of disease utilizing compositions comprising the AM peptides and antibodies of the present invention. The methods of the present invention also provide for experimental models for use in identifying the role of AM in pancreatic physiology. The methods pertaining to rat isolated islets have shown that AM inhibits insulin secretion in a dose-dependent manner. The monoclonal antibody MoAb-G6, which neutralizes AM bioactivity, was shown by the methods of the present invention to increase insulin release fivefold, an effect that was reversed by the addition of synthetic AM.
Patent EP-0792950-A1 (EP)
Inventor: YOSHIOKA MASAHIRO
IPC: B01D21/24
Filed: 1996-09-26
Abstract: The present invention provides a method of and an apparatus for efficiently and economically discharging solid particles, which have sedimented on the bottom of a tank, out from the tank. A liquid is ejected from an ejector installed in the tank to move the sedimented solid particles to a predetermined place from which the sedimented solid particles are discharged out from the tank. Further, a solution which contains sedimentary solid particles is cooled and the solid particles are efficiently separated by a solid-liquid separator.
Patent EP-0868130-A1 (EP)
Inventor: GILBERT DAVID
IPC: A47B88/80
Filed: 1996-10-10
Abstract: Furniture for containing computer equipment is disclosed, where the computer equipment can be concealed when not in use. The furniture is in the form of a desk or table which has at least one normal drawer and at least one false drawer front which can be moved relative to or removed from the furniture (desk, credenza and so on). Computer equipment is mounted in the furniture carcass. When the equipment is in use, the false front is pivoted downward or removed, thereby exposing the equipment for easy access, for example via the disc ports. When not in use, the false drawer is positioned vertically and is fabricated to match the front of the normal drawer in appearance.